Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective

Value in Health(2024)10.1016/j.jval.2023.11.006Source: DataRank Database

Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective is a research paper published in Value in Health (2024). On theSindex it has a DataRank of 0.434. It has been cited 17 times.

N/A

0.434DataRank · unranked

Scored on demand from live citation data

17 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 5.25)OA: hybridTopics (37)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.434

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (9)

Nadi Shahid,Mira G.P. Zuidgeest,Yared Santa-Ana-Tellez,Milou Hogervorst,Wim Goettsch ORCID

Live enrichment

PubMed:38043711 OpenAlex:https://openalex.org/W4389265557

IMI

Grant: 831458

Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials

Horizon 2020

Innovative Medicines Initiative

European Federation of Pharmaceutical Industries and Associations

Horizon 2020 Framework Programme

FWCI

5.25

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttp://www.valueinhealthjournal.com/article/S1098301523061971/pdf

publisherhttp://www.valueinhealthjournal.com/article/S1098301523061971/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1098301523061971?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1098301523061971?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jval.2023.11.006

Fields of Study

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyBiosimilars and Bioanalytical MethodsHumansDecision MakingTechnology Assessment, BiomedicalCost-Benefit AnalysisResearch DesignData Collection

MeSH Terms

Cost-Benefit AnalysisData CollectionDecision MakingHumansResearch DesignTechnology Assessment, Biomedical

Keywords

Perspective (graphical)Health technologyManagement scienceMedicineKnowledge managementProcess managementBusinessEngineering ethicsPolitical scienceComputer scienceEngineeringHealth careArtificial intelligenceGeneralizabilityPatient CentricityDecentralized TrialsTechnology Assessment, BiomedicalResearch DesignCost-Benefit AnalysisData CollectionDecision MakingHumans

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justice

Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective

FAIR Checklist

DataRank Breakdown

Authors (9)

Funding (5 grants)

Impact

Open Access

Topics